Literature DB >> 14557015

Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma.

Tomasz Pochylski1, Anna Kwaśniewska.   

Abstract

OBJECTIVES: Research data on the K-RAS gene mutation in carcinogenesis of the uterine cervix remain contradictory. Hence the question of whether spot mutations of the RAS genes or their excessive expression are an indispensable condition for the generation of the neoplastic phenotype of the cervical epithelial cell remains without an explicit answer. AIM OF THE STUDY: The purpose of the study was identification of point mutation in codons 12 and 13 of the first exon of K-RAS gene in DNA from squamous cell cervical carcinomas, high grade dysplasias, and normal epithelium.
MATERIAL AND METHODS: The study group consisted of 35 postoperative tissues from patients diagnosed with high grade dysplasia and 29 postoperative tissues from patients diagnosed with squamous cell cervical carcinoma. The control group consisted of normal cervical tissue specimens obtained from 33 patients who underwent hysterectomy due to uterine leiomyomas. Identification of point mutation in codons 12 and 13 of the first exon of K-RAS genes was performed using polymerase chain reaction (PCR)-SSCP technique.
RESULTS: PCR-SSCP analysis did not reveal the presence of point mutation in codons 12 and 13 of K-RAS gene in any of the analyzed cases.

Entities:  

Mesh:

Year:  2003        PMID: 14557015     DOI: 10.1016/s0301-2115(03)00205-7

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Authors:  Alessandro D Santin; Michael W Sill; D Scott McMeekin; Mario M Leitao; Jubilee Brown; Gregory P Sutton; Linda Van Le; Patricia Griffin; Cecelia H Boardman
Journal:  Gynecol Oncol       Date:  2011-09       Impact factor: 5.482

2.  Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.

Authors:  Vanessa Deschoolmeester; Veerle Van Marck; Marc Baay; Christine Weyn; Peter Vermeulen; Eric Van Marck; Filip Lardon; Veronique Fontaine; Jan B Vermorken
Journal:  BMC Cancer       Date:  2010-03-26       Impact factor: 4.430

3.  Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma.

Authors:  Vasileios Papanikolaou; Aristeidis Chrysovergis; Stylianos Mastronikolis; Evangelos Tsiambas; Vasileios Ragos; Dimitrios Peschos; Despoina Spyropoulou; Pavlos Pantos; Athanasios Niotis; Nicholas Mastronikolis; Efthymios Kyrodimos
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  Coexistence of K-ras mutations and HPV infection in colon cancer.

Authors:  Nur Buyru; Ayda Tezol; Nejat Dalay
Journal:  BMC Cancer       Date:  2006-05-04       Impact factor: 4.430

5.  KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).

Authors:  Andrea Casadei Gardini; Laura Capelli; Paola Ulivi; Massimo Giannini; Eva Freier; Stefano Tamberi; Emanuela Scarpi; Alassandro Passardi; Wainer Zoli; Angela Ragazzini; Dino Amadori; Giovanni Luca Frassineti
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.